Global Herpes Simplex Virus Infections Market Insights, Forecast to 2029

Global Herpes Simplex Virus Infections Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 General Treatment
1.2.3 Antiviral Therapy
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Herpes Simplex Virus Infections Market Perspective (2018-2029)
2.2 Global Herpes Simplex Virus Infections Growth Trends by Region
2.2.1 Herpes Simplex Virus Infections Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Herpes Simplex Virus Infections Historic Market Size by Region (2018-2023)
2.2.3 Herpes Simplex Virus Infections Forecasted Market Size by Region (2024-2029)
2.3 Herpes Simplex Virus Infections Market Dynamics
2.3.1 Herpes Simplex Virus Infections Industry Trends
2.3.2 Herpes Simplex Virus Infections Market Drivers
2.3.3 Herpes Simplex Virus Infections Market Challenges
2.3.4 Herpes Simplex Virus Infections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Herpes Simplex Virus Infections by Players
3.1.1 Global Herpes Simplex Virus Infections Revenue by Players (2018-2023)
3.1.2 Global Herpes Simplex Virus Infections Revenue Market Share by Players (2018-2023)
3.2 Global Herpes Simplex Virus Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Herpes Simplex Virus Infections, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Herpes Simplex Virus Infections Market Concentration Ratio
3.4.1 Global Herpes Simplex Virus Infections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infections Revenue in 2022
3.5 Global Key Players of Herpes Simplex Virus Infections Head office and Area Served
3.6 Global Key Players of Herpes Simplex Virus Infections, Product and Application
3.7 Global Key Players of Herpes Simplex Virus Infections, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Simplex Virus Infections Breakdown Data by Type
4.1 Global Herpes Simplex Virus Infections Historic Market Size by Type (2018-2023)
4.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2024-2029)
5 Herpes Simplex Virus Infections Breakdown Data by Application
5.1 Global Herpes Simplex Virus Infections Historic Market Size by Application (2018-2023)
5.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Herpes Simplex Virus Infections Market Size (2018-2029)
6.2 North America Herpes Simplex Virus Infections Market Size by Type
6.2.1 North America Herpes Simplex Virus Infections Market Size by Type (2018-2023)
6.2.2 North America Herpes Simplex Virus Infections Market Size by Type (2024-2029)
6.2.3 North America Herpes Simplex Virus Infections Market Share by Type (2018-2029)
6.3 North America Herpes Simplex Virus Infections Market Size by Application
6.3.1 North America Herpes Simplex Virus Infections Market Size by Application (2018-2023)
6.3.2 North America Herpes Simplex Virus Infections Market Size by Application (2024-2029)
6.3.3 North America Herpes Simplex Virus Infections Market Share by Application (2018-2029)
6.4 North America Herpes Simplex Virus Infections Market Size by Country
6.4.1 North America Herpes Simplex Virus Infections Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Herpes Simplex Virus Infections Market Size by Country (2018-2023)
6.4.3 North America Herpes Simplex Virus Infections Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Herpes Simplex Virus Infections Market Size (2018-2029)
7.2 Europe Herpes Simplex Virus Infections Market Size by Type
7.2.1 Europe Herpes Simplex Virus Infections Market Size by Type (2018-2023)
7.2.2 Europe Herpes Simplex Virus Infections Market Size by Type (2024-2029)
7.2.3 Europe Herpes Simplex Virus Infections Market Share by Type (2018-2029)
7.3 Europe Herpes Simplex Virus Infections Market Size by Application
7.3.1 Europe Herpes Simplex Virus Infections Market Size by Application (2018-2023)
7.3.2 Europe Herpes Simplex Virus Infections Market Size by Application (2024-2029)
7.3.3 Europe Herpes Simplex Virus Infections Market Share by Application (2018-2029)
7.4 Europe Herpes Simplex Virus Infections Market Size by Country
7.4.1 Europe Herpes Simplex Virus Infections Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Herpes Simplex Virus Infections Market Size by Country (2018-2023)
7.4.3 Europe Herpes Simplex Virus Infections Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Herpes Simplex Virus Infections Market Size (2018-2029)
8.2 China Herpes Simplex Virus Infections Market Size by Type
8.2.1 China Herpes Simplex Virus Infections Market Size by Type (2018-2023)
8.2.2 China Herpes Simplex Virus Infections Market Size by Type (2024-2029)
8.2.3 China Herpes Simplex Virus Infections Market Share by Type (2018-2029)
8.3 China Herpes Simplex Virus Infections Market Size by Application
8.3.1 China Herpes Simplex Virus Infections Market Size by Application (2018-2023)
8.3.2 China Herpes Simplex Virus Infections Market Size by Application (2024-2029)
8.3.3 China Herpes Simplex Virus Infections Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Herpes Simplex Virus Infections Market Size (2018-2029)
9.2 Asia Herpes Simplex Virus Infections Market Size by Type
9.2.1 Asia Herpes Simplex Virus Infections Market Size by Type (2018-2023)
9.2.2 Asia Herpes Simplex Virus Infections Market Size by Type (2024-2029)
9.2.3 Asia Herpes Simplex Virus Infections Market Share by Type (2018-2029)
9.3 Asia Herpes Simplex Virus Infections Market Size by Application
9.3.1 Asia Herpes Simplex Virus Infections Market Size by Application (2018-2023)
9.3.2 Asia Herpes Simplex Virus Infections Market Size by Application (2024-2029)
9.3.3 Asia Herpes Simplex Virus Infections Market Share by Application (2018-2029)
9.4 Asia Herpes Simplex Virus Infections Market Size by Region
9.4.1 Asia Herpes Simplex Virus Infections Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Herpes Simplex Virus Infections Market Size by Region (2018-2023)
9.4.3 Asia Herpes Simplex Virus Infections Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Type
10.2.1 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Application
10.3.1 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Country
10.4.1 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Admedus Limited
11.1.1 Admedus Limited Company Details
11.1.2 Admedus Limited Business Overview
11.1.3 Admedus Limited Herpes Simplex Virus Infections Introduction
11.1.4 Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.1.5 Admedus Limited Recent Developments
11.2 Agenus Inc.
11.2.1 Agenus Inc. Company Details
11.2.2 Agenus Inc. Business Overview
11.2.3 Agenus Inc. Herpes Simplex Virus Infections Introduction
11.2.4 Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.2.5 Agenus Inc. Recent Developments
11.3 Aicuris Anti-infective Cures Gmbh
11.3.1 Aicuris Anti-infective Cures Gmbh Company Details
11.3.2 Aicuris Anti-infective Cures Gmbh Business Overview
11.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Introduction
11.3.4 Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.3.5 Aicuris Anti-infective Cures Gmbh Recent Developments
11.4 Asahi Kasei Corporation
11.4.1 Asahi Kasei Corporation Company Details
11.4.2 Asahi Kasei Corporation Business Overview
11.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Introduction
11.4.4 Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.4.5 Asahi Kasei Corporation Recent Developments
11.5 Chimerix Inc.
11.5.1 Chimerix Inc. Company Details
11.5.2 Chimerix Inc. Business Overview
11.5.3 Chimerix Inc. Herpes Simplex Virus Infections Introduction
11.5.4 Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.5.5 Chimerix Inc. Recent Developments
11.6 Clinigen Group Plc
11.6.1 Clinigen Group Plc Company Details
11.6.2 Clinigen Group Plc Business Overview
11.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Introduction
11.6.4 Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.6.5 Clinigen Group Plc Recent Developments
11.7 Daewoong Pharmaceutical Co., Ltd.
11.7.1 Daewoong Pharmaceutical Co., Ltd. Company Details
11.7.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
11.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Introduction
11.7.4 Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.7.5 Daewoong Pharmaceutical Co., Ltd. Recent Developments
11.8 F. Hoffmann-la Roche Ltd.
11.8.1 F. Hoffmann-la Roche Ltd. Company Details
11.8.2 F. Hoffmann-la Roche Ltd. Business Overview
11.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Introduction
11.8.4 F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.8.5 F. Hoffmann-la Roche Ltd. Recent Developments
11.9 Glaxosmithkline Plc
11.9.1 Glaxosmithkline Plc Company Details
11.9.2 Glaxosmithkline Plc Business Overview
11.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Introduction
11.9.4 Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.9.5 Glaxosmithkline Plc Recent Developments
11.10 Maruho Co. Ltd.
11.10.1 Maruho Co. Ltd. Company Details
11.10.2 Maruho Co. Ltd. Business Overview
11.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Introduction
11.10.4 Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.10.5 Maruho Co. Ltd. Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Herpes Simplex Virus Infections Introduction
11.11.4 Merck Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.11.5 Merck Recent Developments
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Herpes Simplex Virus Infections Introduction
11.12.4 Mylan Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.12.5 Mylan Recent Developments
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Herpes Simplex Virus Infections Introduction
11.13.4 Novartis Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.13.5 Novartis Recent Developments
11.14 Sanofi Pasteur
11.14.1 Sanofi Pasteur Company Details
11.14.2 Sanofi Pasteur Business Overview
11.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Introduction
11.14.4 Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.14.5 Sanofi Pasteur Recent Developments
11.15 Teva Pharmaceutical Industries Ltd.
11.15.1 Teva Pharmaceutical Industries Ltd. Company Details
11.15.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Introduction
11.15.4 Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2018-2023)
11.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Herpes Simplex Virus Infections Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of General Treatment
Table 3. Key Players of Antiviral Therapy
Table 4. Global Herpes Simplex Virus Infections Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Herpes Simplex Virus Infections Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Herpes Simplex Virus Infections Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Herpes Simplex Virus Infections Market Share by Region (2018-2023)
Table 8. Global Herpes Simplex Virus Infections Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Herpes Simplex Virus Infections Market Share by Region (2024-2029)
Table 10. Herpes Simplex Virus Infections Market Trends
Table 11. Herpes Simplex Virus Infections Market Drivers
Table 12. Herpes Simplex Virus Infections Market Challenges
Table 13. Herpes Simplex Virus Infections Market Restraints
Table 14. Global Herpes Simplex Virus Infections Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Herpes Simplex Virus Infections Revenue Share by Players (2018-2023)
Table 16. Global Top Herpes Simplex Virus Infections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2022)
Table 17. Global Herpes Simplex Virus Infections Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Herpes Simplex Virus Infections Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Herpes Simplex Virus Infections, Headquarters and Area Served
Table 20. Global Key Players of Herpes Simplex Virus Infections, Product and Application
Table 21. Global Key Players of Herpes Simplex Virus Infections, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Herpes Simplex Virus Infections Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Herpes Simplex Virus Infections Revenue Market Share by Type (2018-2023)
Table 25. Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Herpes Simplex Virus Infections Revenue Market Share by Type (2024-2029)
Table 27. Global Herpes Simplex Virus Infections Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Herpes Simplex Virus Infections Revenue Share by Application (2018-2023)
Table 29. Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Herpes Simplex Virus Infections Revenue Share by Application (2024-2029)
Table 31. North America Herpes Simplex Virus Infections Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Herpes Simplex Virus Infections Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Herpes Simplex Virus Infections Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Herpes Simplex Virus Infections Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Herpes Simplex Virus Infections Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Herpes Simplex Virus Infections Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Herpes Simplex Virus Infections Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Herpes Simplex Virus Infections Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Herpes Simplex Virus Infections Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Herpes Simplex Virus Infections Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Herpes Simplex Virus Infections Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Herpes Simplex Virus Infections Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Herpes Simplex Virus Infections Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Herpes Simplex Virus Infections Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Herpes Simplex Virus Infections Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Herpes Simplex Virus Infections Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Herpes Simplex Virus Infections Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Herpes Simplex Virus Infections Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Herpes Simplex Virus Infections Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Herpes Simplex Virus Infections Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Herpes Simplex Virus Infections Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Herpes Simplex Virus Infections Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Herpes Simplex Virus Infections Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Herpes Simplex Virus Infections Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Herpes Simplex Virus Infections Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size by Country (2024-2029) & (US$ Million)
Table 63. Admedus Limited Company Details
Table 64. Admedus Limited Business Overview
Table 65. Admedus Limited Herpes Simplex Virus Infections Product
Table 66. Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 67. Admedus Limited Recent Developments
Table 68. Agenus Inc. Company Details
Table 69. Agenus Inc. Business Overview
Table 70. Agenus Inc. Herpes Simplex Virus Infections Product
Table 71. Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 72. Agenus Inc. Recent Developments
Table 73. Aicuris Anti-infective Cures Gmbh Company Details
Table 74. Aicuris Anti-infective Cures Gmbh Business Overview
Table 75. Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Product
Table 76. Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 77. Aicuris Anti-infective Cures Gmbh Recent Developments
Table 78. Asahi Kasei Corporation Company Details
Table 79. Asahi Kasei Corporation Business Overview
Table 80. Asahi Kasei Corporation Herpes Simplex Virus Infections Product
Table 81. Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 82. Asahi Kasei Corporation Recent Developments
Table 83. Chimerix Inc. Company Details
Table 84. Chimerix Inc. Business Overview
Table 85. Chimerix Inc. Herpes Simplex Virus Infections Product
Table 86. Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 87. Chimerix Inc. Recent Developments
Table 88. Clinigen Group Plc Company Details
Table 89. Clinigen Group Plc Business Overview
Table 90. Clinigen Group Plc Herpes Simplex Virus Infections Product
Table 91. Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 92. Clinigen Group Plc Recent Developments
Table 93. Daewoong Pharmaceutical Co., Ltd. Company Details
Table 94. Daewoong Pharmaceutical Co., Ltd. Business Overview
Table 95. Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Product
Table 96. Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 97. Daewoong Pharmaceutical Co., Ltd. Recent Developments
Table 98. F. Hoffmann-la Roche Ltd. Company Details
Table 99. F. Hoffmann-la Roche Ltd. Business Overview
Table 100. F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Product
Table 101. F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 102. F. Hoffmann-la Roche Ltd. Recent Developments
Table 103. Glaxosmithkline Plc Company Details
Table 104. Glaxosmithkline Plc Business Overview
Table 105. Glaxosmithkline Plc Herpes Simplex Virus Infections Product
Table 106. Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 107. Glaxosmithkline Plc Recent Developments
Table 108. Maruho Co. Ltd. Company Details
Table 109. Maruho Co. Ltd. Business Overview
Table 110. Maruho Co. Ltd. Herpes Simplex Virus Infections Product
Table 111. Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 112. Maruho Co. Ltd. Recent Developments
Table 113. Merck Company Details
Table 114. Merck Business Overview
Table 115. Merck Herpes Simplex Virus Infections Product
Table 116. Merck Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 117. Merck Recent Developments
Table 118. Mylan Company Details
Table 119. Mylan Business Overview
Table 120. Mylan Herpes Simplex Virus Infections Product
Table 121. Mylan Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 122. Mylan Recent Developments
Table 123. Novartis Company Details
Table 124. Novartis Business Overview
Table 125. Novartis Herpes Simplex Virus Infections Product
Table 126. Novartis Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 127. Novartis Recent Developments
Table 128. Sanofi Pasteur Company Details
Table 129. Sanofi Pasteur Business Overview
Table 130. Sanofi Pasteur Herpes Simplex Virus Infections Product
Table 131. Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 132. Sanofi Pasteur Recent Developments
Table 133. Teva Pharmaceutical Industries Ltd. Company Details
Table 134. Teva Pharmaceutical Industries Ltd. Business Overview
Table 135. Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Product
Table 136. Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2018-2023) & (US$ Million)
Table 137. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Simplex Virus Infections Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Herpes Simplex Virus Infections Market Share by Type: 2022 VS 2029
Figure 3. General Treatment Features
Figure 4. Antiviral Therapy Features
Figure 5. Global Herpes Simplex Virus Infections Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Herpes Simplex Virus Infections Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Herpes Simplex Virus Infections Report Years Considered
Figure 11. Global Herpes Simplex Virus Infections Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Herpes Simplex Virus Infections Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Herpes Simplex Virus Infections Market Share by Region: 2022 VS 2029
Figure 14. Global Herpes Simplex Virus Infections Market Share by Players in 2022
Figure 15. Global Top Herpes Simplex Virus Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infections as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Herpes Simplex Virus Infections Revenue in 2022
Figure 17. North America Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Herpes Simplex Virus Infections Market Share by Type (2018-2029)
Figure 19. North America Herpes Simplex Virus Infections Market Share by Application (2018-2029)
Figure 20. North America Herpes Simplex Virus Infections Market Share by Country (2018-2029)
Figure 21. United States Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Herpes Simplex Virus Infections Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Herpes Simplex Virus Infections Market Share by Type (2018-2029)
Figure 25. Europe Herpes Simplex Virus Infections Market Share by Application (2018-2029)
Figure 26. Europe Herpes Simplex Virus Infections Market Share by Country (2018-2029)
Figure 27. Germany Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Herpes Simplex Virus Infections Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Herpes Simplex Virus Infections Market Share by Type (2018-2029)
Figure 35. China Herpes Simplex Virus Infections Market Share by Application (2018-2029)
Figure 36. Asia Herpes Simplex Virus Infections Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Herpes Simplex Virus Infections Market Share by Type (2018-2029)
Figure 38. Asia Herpes Simplex Virus Infections Market Share by Application (2018-2029)
Figure 39. Asia Herpes Simplex Virus Infections Market Share by Region (2018-2029)
Figure 40. Japan Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Herpes Simplex Virus Infections Market Share by Country (2018-2029)
Figure 50. Brazil Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Herpes Simplex Virus Infections Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Admedus Limited Revenue Growth Rate in Herpes Simplex Virus Infections Business (2018-2023)
Figure 57. Agenus Inc. Revenue Growth Rate in Herpes Simplex Virus Infections Business (2018-2023)
Figure 58. Aicuris Anti-infective Cures Gmbh Revenue Growth Rate in Herpes Simplex Virus Infections Business (2018-2023)
Figure 59. Asahi Kasei Corporation Revenue Growth Rate i

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs